Aptevo director exercises 400 RSUs into common stock
Aptevo Therapeutics Inc. director Grant Grady III exercised 400 Restricted Stock Units (RSUs) into 400 shares of common stock on August 6, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Aptevo Therapeutics Inc. director Grant Grady III exercised 400 Restricted Stock Units (RSUs) into 400 shares of common stock on August 6, 2026. The RSUs convert into common stock on a one-for-one basis. Following the transaction, Grady directly holds 1,150 shares of Aptevo common stock, while the corresponding RSU position was reduced to zero.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit F1, F2 | 400 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 400 | -- | -- |
Footnotes (2)
- F1. Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
- F2. On August 6, 2025, the reporting person was granted 7,200 (400 post-split) RSUs, vesting on the first anniversary of the date of grant.
Key Figures
Key Terms
Restricted Stock Unit financial
derivative security financial
par value financial
vest financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Aptevo Therapeutics (APVO) director Grant Grady III report in this Form 4?
What type of securities did the RSUs convert into for Aptevo Therapeutics (APVO)?
How many Restricted Stock Units did Grant Grady III exercise in Aptevo Therapeutics (APVO)?
When were the Aptevo Therapeutics (APVO) RSUs originally granted to Grant Grady III?
AI-generated analysis. How Rhea-AI works. Not financial advice.